Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
9 "Inha Jung"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Pharmacotherapy
Article image
Glycemic Improvement with Low-Dose Dulaglutide Is Associated with Leptin and Obestatin Modulation in Type 2 Diabetes Mellitus
Inha Jung, Hangseok Choi, In Young Choi, Hyun Joo Cho, So Young Park, Da Young Lee, Ji A Seo, Nan Hee Kim, Ji Hee Yu
Diabetes Metab J. 2026;50(3):565-575.   Published online November 24, 2025
DOI: https://doi.org/10.4093/dmj.2025.0681
  • 3,676 View
  • 84 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic control through insulinotropic and anorectic effects. However, the role of adipokines and appetite-related hormones in mediating the glycemic response remains unclear. This study evaluated changes in abdominal fat, food cravings, and circulating adipokines and gut hormones following dulaglutide treatment and identified predictors of glycemic improvement in type 2 diabetes mellitus (T2DM).
Methods
In this 24-week prospective observational study, 82 patients with T2DM and glycosylated hemoglobin (HbA1c) levels ≥7.0% despite standard therapy received dulaglutide 0.75 mg once weekly. Abdominal computed tomography, the General Food Cravings Questionnaire-Trait, and fasting levels of leptin, adiponectin, obestatin, ghrelin, and resistin were assessed at baseline and week 24. Glycemic responders were defined as those with an HbA1c reduction ≥0.5% and/or HbA1c <7.0% at 24 weeks. Multivariable regression analysis was performed to identify the factors associated with glycemic improvement.
Results
Among the 67 patients who completed the study, dulaglutide significantly reduced HbA1c, food cravings, leptin, and adiponectin levels. Obestatin levels increased modestly. Responders showed greater improvement in β-cell function and more pronounced reductions in food cravings. In the adjusted models, a decrease in leptin and an increase in obestatin were independently associated with HbA1c reduction, while decreased adiponectin was associated with poorer glycemic outcomes. Changes in body mass index or abdominal fat were not associated with glycemic improvement.
Conclusion
Dulaglutide improved glycemic control through mechanisms beyond weight reduction. Hormonal changes in leptin, adiponectin, and obestatin may help predict responses to GLP-1 RAs therapy.

Citations

Citations to this article as recorded by  
  • Glucagon-like peptide-1 receptor agonists and tirzepatide are associated with reduced mortality, cardiovascular, and psychiatric risks in patients with hidradenitis suppurativa and type 2 diabetes and/or obesity: a retrospective cohort study
    Inga C. Brouer, Aida Zani, Henning Olbrich, Ralf J. Ludwig, Diamant Thaçi
    Frontiers in Medicine.2026;[Epub]     CrossRef
Complications
Article image
Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
Inha Jung, Seungyoon Nam, Da Young Lee, So Young Park, Ji Hee Yu, Ji A Seo, Dae Ho Lee, Nan Hee Kim
Diabetes Metab J. 2024;48(6):1126-1134.   Published online July 1, 2024
DOI: https://doi.org/10.4093/dmj.2023.0377
  • 9,491 View
  • 174 Download
  • 13 Web of Science
  • 12 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Although the prevalence of diabetic kidney disease (DKD) is increasing, reliable biomarkers for its early detection are scarce. This study aimed to evaluate the association of adenosine and succinate levels and their related pathways, including hyaluronic acid (HA) synthesis, with DKD.
Methods
We examined 235 participants and categorized them into three groups: healthy controls; those with diabetes but without DKD; and those with DKD, which was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2. We compared the concentrations of urinary adenosine, succinate, and HA and the serum levels of cluster of differentiation 39 (CD39) and CD73, which are involved in adenosine generation, among the groups with DKD or albuminuria. In addition, we performed multiple logistic regression analysis to evaluate the independent association of DKD or albuminuria with the metabolites after adjusting for risk factors. We also showed the association of these metabolites with eGFR measured several years before enrollment. This study was registered with the Clinical Research Information Service (https://cris.nih.go.kr; Registration number: KCT0003573).
Results
Urinary succinate and serum CD39 levels were higher in the DKD group than in the control and non-DKD groups. Correlation analysis consistently linked urinary succinate and serum CD39 concentrations with eGFR, albuminuria, and ΔeGFR, which was calculated retrospectively. However, among the various metabolites studied, only urinary succinate was identified as an independent indicator of DKD and albuminuria.
Conclusion
Among several potential metabolites, only urinary succinate was independently associated with DKD. These findings hold promise for clinical application in the management of DKD.

Citations

Citations to this article as recorded by  
  • Diabetic kidney disease: integrating multi-omics insights, artificial intelligence, and novel therapeutics for precision medicine
    Tao Li, Kaili Chen, Yiting Sun, Linqi Zhang
    Frontiers in Genetics.2026;[Epub]     CrossRef
  • Spatial metabolomics: A new tool for unravelling the metabolic disorders and heterogeneity in diabetic kidney disease (Review)
    Hanfei Li, Yuxi Li, Bo Zhang, Wenhao Cheng, Guowei Ma, Jin Rong, Shiru Duan, Di Feng, Tingting Zhao
    International Journal of Molecular Medicine.2026; 57(4): 1.     CrossRef
  • Next-Generation Redox Mediators: Itaconate, Nitro-Fatty Acids, Reactive Sulfur Species and Succinate as Emerging Switches in Predictive Redox Medicine
    Luca Gammeri, Alessandro Allegra, Fabio Stagno, Sebastiano Gangemi
    Antioxidants.2026; 15(4): 427.     CrossRef
  • Metabolic Reprogramming and Immunometabolic Dysregulation in Diabetic Kidney Disease: From Pathogenesis to Precision Multi-target Therapies
    Ziyue Zhang, Yilun Qu, Xiaochen Wang, Yuwei Ji, Jin Yao, Weizhu Deng, Guannan Sun, Hua Xu, Xiangmei Chen, Quan Hong
    Research.2026;[Epub]     CrossRef
  • AI-assisted metabolomic profiling identifies candidate metabolites associated with diabetic kidney disease staging in a Korean cohort
    Inha Jung, Sungjin Park, Moongi Ji, So Young Park, Da Young Lee, Ji Hee Yu, Ji A. Seo, Man-Jeong Paik, Hyeong Kyu Park, Soon Hyo Kwon, Dae Ho Lee, Nan Hee Kim
    iScience.2026; 29(10): 117506.     CrossRef
  • Trifolirhizin: A Phytochemical with Multiple Pharmacological Properties
    Varun Jaiswal, Hae-Jeung Lee
    Molecules.2025; 30(2): 383.     CrossRef
  • The role of redox signaling in mitochondria and endoplasmic reticulum regulation in kidney diseases
    Omar Emiliano Aparicio-Trejo, Estefani Yaquelin Hernández-Cruz, Laura María Reyes-Fermín, Zeltzin Alejandra Ceja-Galicia, José Pedraza-Chaverri
    Archives of Toxicology.2025; 99(5): 1865.     CrossRef
  • Chronic succinate exposure does not cause liver injury
    Joseph Balnis, Emily L. Jackson, Lisa A. Drake, Catherine E. Vincent, Hwajeong Lee, Harold A. Singer, Ariel Jaitovich
    American Journal of Physiology-Endocrinology and Metabolism.2025; 329(1): E39.     CrossRef
  • Succinate Facilitates CD4+ T Cell Infiltration and CCL1 Production to Promote Myofibroblast Activation and Renal Fibrosis in UUO Mice
    Yuandong Tao, Wei Zhang, Dehong Liu, Hualin Cao, Xiaoyu Yi, Xiangling Deng, Pin Li, Xiaoli Shen, Huixia Zhou
    Journal of Inflammation Research.2025; Volume 18: 7827.     CrossRef
  • From inflammation to healing: the crucial role of GPR91 activation and SDH inhibition in chronic diabetic wound recovery
    Hengdeng Liu, Shixin Zhao, Hanwen Wang, Xuefeng He, Suyue Gao, Minmin Su, Miao Zhen, Shuying Chen, Lei Chen, Julin Xie
    Stem Cell Research & Therapy.2025;[Epub]     CrossRef
  • Network pharmacology and untargeted metabolomics reveal the mechanisms of Bushen Kaixuan Tongluo formula in diabetic kidney disease
    You Wang, Baosheng Zhao, Zhuqing Yang, Lingling Qin, Haiyan Wang, Cuiyan Lv, Tonghua Liu, Guangrui Huang
    Journal of Chromatography B.2025; 1265: 124752.     CrossRef
  • Oxidative Stress, Metabolic Impairment and Neuroinflammation are Associated With Target Organ Damage in SHRSP
    S Hojná, L Mráziková, A Shánělová, H Pelantová, A Montezano, R Touyz, L Maletínská, J Kuneš
    Physiological Research.2025; : 779.     CrossRef
Sulwon Lecture 2023
Metabolic Risk/Epidemiology
Article image
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
Inha Jung, Dae-Jeong Koo, Won-Young Lee
Diabetes Metab J. 2024;48(3):327-339.   Published online February 2, 2024
DOI: https://doi.org/10.4093/dmj.2023.0350
  • 29,723 View
  • 757 Download
  • 57 Web of Science
  • 57 Crossref
AbstractAbstract PDFPubReader   ePub   
It has been generally accepted that insulin resistance (IR) and reduced insulin secretory capacity are the basic pathogenesis of type 2 diabetes mellitus (T2DM). In addition to genetic factors, the persistence of systemic inflammation caused by obesity and the associated threat of lipotoxicity increase the risk of T2DM. In particular, the main cause of IR is obesity and subjects with T2DM have a higher body mass index (BMI) than normal subjects according to recent studies. The prevalence of T2DM with IR has increased with increasing BMI during the past three decades. According to recent studies, homeostatic model assessment of IR was increased compared to that of the 1990s. Rising prevalence of obesity in Korea have contributed to the development of IR, non-alcoholic fatty liver disease and T2DM and cutting this vicious cycle is important. My colleagues and I have investigated this pathogenic mechanism on this theme through clinical and experimental studies over 20 years and herein, I would like to summarize some of our studies with deep gratitude for receiving the prestigious 2023 Sulwon Award.

Citations

Citations to this article as recorded by  
  • Recent Trends for Computational Enriched Diabetic Retinopathy Assessment: A Systematic Review
    Hrijuta Datta, Preity, Ashish Kumar Bhandari
    Archives of Computational Methods in Engineering.2026; 33(1): 1227.     CrossRef
  • Macrophage Plg-RKT expression promotes diet-induced obesity and metabolic dysfunction-associated steatotic liver disease
    Lindsey A. Miles, Hongdong Bai, Sagarika Chakrabarty, Nagyung Baik, Yuqing Zhang, Robert J. Parmer, Fahumiya Samad
    Journal of Thrombosis and Haemostasis.2026; 24(1): 241.     CrossRef
  • Attention-based graph neural network framework for non-invasive CAP score prediction in fatty liver disease via body modeling
    Ghasem Sadeghi Bajestani, Fatemeh Makhloughi, Ayoub Basham, Ebrahim Evazi, Mahdiyeh Razm Pour, Roohallah Alizadehsani, Farkhondeh Razmpour
    Physical and Engineering Sciences in Medicine.2026; 49(1): 183.     CrossRef
  • LGALS3BP Induces Insulin Resistance via TLR2-IKKα/β Pathway-Mediated IRS1 Serine Phosphorylation
    Minjeong Sung, Dae-Hwan Kim, Eun-Gene Sun, Jun-Eul Hwang, Sang-Hee Cho, Ik-Joo Chung, Hyun-Jeong Shim, Woo Kyun Bae
    Endocrinology and Metabolism.2026; 41(1): 121.     CrossRef
  • Hepatorenal vulnerability flagged by glomerular hyperfiltration in metabolic liver disease: a large health-screening cohort evidence
    Dae-Jeong Koo, Yun Tae Kim, Sun-Joon Moon, Hyemi Kwon, Se Eun Park, Sang Min Lee, Cheol-Young Park, Won-Young Lee, Sung Rae Cho, Eun-Jung Rhee
    Diabetology & Metabolic Syndrome.2026;[Epub]     CrossRef
  • Kudzu root-derived carbon dots modulate gut microbiota and metabolites for pan-organ targeted macrophage polarization in synergistic diabetes therapy
    Jianing Yi, Yuanyu Tang, Yilin Chen, Liang Chen, Dongxue Geng, Luyao Liu, Jie Yu, Lianhong Zou, Jie Zeng, Minhuan Lan, Wenjie Gao, Ming Gao
    Biomaterials.2026; 329: 123967.     CrossRef
  • Development of a machine learning-based model for prediction of diabetes risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Sijie Yang, Ruiqing Mo, Wenqiang Wang, Puxiang Zhen, Wentian Han
    BMJ Open.2026; 16(1): e107239.     CrossRef
  • Liver fibrosis biomarkers as a prognostic tool beyond the defining components in cardiovascular-kidney-metabolic syndrome
    Zhenyang Cao, Binyan Chen, Jinghao Zhou, Jijie Jin, Dmitry Abramov, Shengzhang Chen, Pan Huang, Jianghua Zhou
    American Journal of Preventive Cardiology.2026; 26: 101438.     CrossRef
  • Exploring the multifaceted roles of beta-defensins in prediabetes: a detailed review
    Nourah Almansour, Amal Hasan, Shaima Albeloushi, Rasheed Ahmad
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Machine Learning–Based Prediction Model Construction for Type 2 Diabetes Mellitus: A Comparison of Algorithms and Multilevel Risk Factor Analysis
    Qian Xu, Ruicong Yu, Huixin Qiu, Yannan Jiang, Jake Ball, Cuirong Xu, Jing Sun, Weibing Ye
    Journal of Diabetes Research.2026;[Epub]     CrossRef
  • Therapeutic potential of EGCG in treating vascular and metabolic disorders
    Zijian Li, Huifang Ge, Suowen Xu, Yijun Wang
    Journal of Functional Foods.2026; 140: 107284.     CrossRef
  • Association Between Thyroid Hormone Sensitivity Indicators and Controlled Attenuation Parameter (CAP) Values in Euthyroid Adults with Overweight/Obesity
    Yifang Zhang, Cuiping Bao, Lingling Liu, Renjiao Liu, Xincheng Wang, Xiaoxuan Guo, Chunjun Li
    Diabetes, Metabolic Syndrome and Obesity.2026; Volume 19: 1.     CrossRef
  • Impact of Fatty Liver Index on Cardiovascular Disease and Mortality across Alcohol Consumption Levels in Young Adults
    Byung-Hun Han, Joonyub Lee, Hun-Sung Kim, Jae-Hyoung Cho, Kyungdo Han, Seung-Hwan Lee
    Endocrinology and Metabolism.2026;[Epub]     CrossRef
  • Thermosensitive TRP channels as dietary modulators of adipose thermogenesis: Implications for energy homeostasis and obesity
    Yashdeep Mukheja, Roshan Lal, Neha Soni, Jasleen Kaur, Pragyanshu Khare, Kanthi Kiran Kondepudi, Kanwaljit Chopra, Mahendra Bishnoi
    Journal of Thermal Biology.2026; 139: 104475.     CrossRef
  • The Impact of Type 2 Diabetes Mellitus on Hepatic Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Study
    Paula Mesquita, Cristiane Macedo, Ana Matos, Carla Henriques, Armando Carvalho, Adélia Simão
    GE - Portuguese Journal of Gastroenterology.2026; 33(1): 413.     CrossRef
  • Borderline liver enzyme patterns and their metabolic–inflammatory signatures: an observational outpatient study
    Erdoğan Özdemir, Turgay Yılmaz
    Frontiers in Medicine.2026;[Epub]     CrossRef
  • Sleep deprivation aggravates hepatocytes steatosis and insulin resistance by regulating exosomal microRNAs
    Xinxin Xu, Lulu Li, Ying Cao, Ying Wang, Chao Yang, Alexander Nikolaevich Orekhov, Yuanfeng Lu, Houbin Chu, Chuanrong Zhao, Guixue Wang, Guohua Song
    Interdisciplinary Medicine.2026;[Epub]     CrossRef
  • Phytic Acid as a Functional Nutrient: Unraveling its Role in Type 2 Diabetes Management and Obesity Control
    Madhan Krishnan, Shyamaladevi Babu
    Molecular Nutrition & Food Research.2026;[Epub]     CrossRef
  • Predictive performance of cardiometabolic indices for prediabetes progression to diabetes and reversion to normoglycemia in adults: a cohort study
    Yilin Zhu, Yangxuan He, Shusheng Fang, Hong Chen, Jingshan Jiang, Yunxiang Ming, Song Leng
    Frontiers in Nutrition.2026;[Epub]     CrossRef
  • TIME-RESTRICTED EATING IN MASLD: THE IMPERATIVE TO PRESERVE MUSCLE MASS AND PREVENT WEIGHT CYCLING FOR SUSTAINABLE CLINICAL BENEFIT
    Yusuf Bünyamin KETENCİ, Hakan DEMİRÖZ, Mehmet AKCA
    Arquivos de Gastroenterologia.2026;[Epub]     CrossRef
  • Global, regional and national burden and trends of non-alcoholic fatty liver disease in women of reproductive age from 1990 to 2021: Insights from the Global burden of disease study 2021
    Yi Yu, Chunxia Zhang, Zirong Liang, Xiang Wang, Jun Wang, Feihu Bai, Dekui Zhang, Yonggang Tian
    Indian Journal of Gastroenterology.2026;[Epub]     CrossRef
  • DN203316, a novel PPARδ agonist, suppresses ferroptotic signaling and fibrogenesis in metabolic dysfunction-associated steatohepatitis
    Ye Jin Kim, Jina Kim, Da Young An, Mihyang Park, Gui-Hwa Jeong, Jonghwa Jin, Mi Kyung Kim, Jungwook Chin, Yeon-Kyung Choi, Keun-Gyu Park
    Experimental & Molecular Medicine.2026; 58(6): 1900.     CrossRef
  • Elevated homocysteine levels are associated with increased diabetes risk in patients with hypertension: a multicenter longitudinal study
    Ya He, Xianwei Tian, Chenru Zhao, Meng Chen, Hongyan Zhang
    Frontiers in Cardiovascular Medicine.2026;[Epub]     CrossRef
  • Adipose tissue distribution in metabolic disease: depot-specific biology, clinical assessment, and therapeutic remodeling
    Anke LiuLi, Tongtong Zhang, Zhonghui Feng
    Frontiers in Endocrinology.2026;[Epub]     CrossRef
  • Extracellular vesicles from steatotic hepatocytes promote endothelial dysfunction and atherogenesis via miR-30b-5p/ELOVL5 axis
    Marie Rhee, Joonyub Lee, Cheol Woon Jung, Jinsung Yang, Won Gun Choi, Young-Hye You, Heon-Seok Park, Eun Young Lee, Eun Kyung Lee, Sung Won Kwon, Young-Bum Kim, Seung-Hwan Lee
    Molecular Therapy.2026; 34(9): 5382.     CrossRef
  • Tissue-Specific Transcriptomics Uncover Exercise-Responsive Immune–Metabolic Regulatory Targets in Obesity
    Yingfeng Chen, Renqing Zhao, Ji Ma, Weidong Zheng, Jian Gong
    Metabolites.2026; 16(7): 472.     CrossRef
  • Revisiting Insulin Resistance in the Pathophysiology of Type 2 Diabetes Mellitus: A Multi-Organ Perspective
    Soo Lim, Seung-Hwan Lee, Robert H. Eckel
    Diabetes & Metabolism Journal.2026; 50(4): 641.     CrossRef
  • Comparative performance of insulin resistance-related indices in predicting adverse cardiovascular events among individuals with NAFLD and MASLD: a multi-center cohort study
    Yanqiu Huang, Yadan Xu, Chenghao Zhang, Wen Gu, Yue Li, Haojia Zhang, Tian Wang, Tangyi Su, Yangchen Lhamu, Yichen Chen, Liang Zhou, Lipeng Hao, Yang Yang, Hui Wang
    Cardiovascular Diabetology.2026;[Epub]     CrossRef
  • Routine biochemical indices for hepatometabolic stratification across the dysglycaemia spectrum: insulin resistance, fibrosis scores, and machine-learning integration
    Pedro Villafruela-Rodríguez-Manzaneque, Jordi Tortosa-Carreres, Antonio Sierra-Rivera, Manuela Morales-Garcés, Laura Sahuquillo-Frias, Goitzane Marcaida-Benito
    Advances in Laboratory Medicine / Avances en Medicina de Laboratorio.2026; 7(3): 211.     CrossRef
  • Expression profiles of selected circulating microRNAs (miR-192-5p and miR-155-3p) in NAFLD and their association with obesity and type 2 diabetes mellitus
    Rana Mohamed, Mohamed M. Sadaty, Emad El-Zayat, Sahar H. Ahmed, Mohamed Awadein, Nahla O. Mousa
    Acta Diabetologica.2026;[Epub]     CrossRef
  • Icariin-loaded liposomal nanoparticles alleviate streptozotocin-induced diabetic hepatopathy associated with modulation of ferroptosis-related and inflammatory signaling
    Badriah A. Hifni, Shaza A. Alyamani, Nasser S. Alqahtani, Ayat B. Al-Ghafari, Huda A. Al Doghaither, Ekramy M. Elmorsy, Manal S. Fawzy, Gehad E. Elshopakey
    BMC Pharmacology and Toxicology.2026;[Epub]     CrossRef
  • Physical activity and type 2 diabetes risk
    Jing Liu, Qingtao Zeng
    Medicine.2026; 105(36): e50570.     CrossRef
  • Therapeutic Potential of Gene‐Modified MSC‐Exos in Insulin Resistance: Mitochondrial Crosstalk and miRNA Regulation
    Qinghua Jia, Bing Li, Yuan Xing, Yuanyuan Zhang, Baodong Gao, Xiangying Li, Xiaoqin Ha
    Journal of Cellular and Molecular Medicine.2026;[Epub]     CrossRef
  • Advances in the application of insulin resistance-related indicators in the clinical evaluation of metabolic dysfunction-associated steatotic liver disease
    Yi Li, Huan Li, Bolun Zhang, Qingming Wu, Hui Long
    Frontiers in Gastroenterology.2026;[Epub]     CrossRef
  • Development and validation of a risk model for non-fatty chronic liver disease in middle-aged and older adults with metabolic syndrome
    Xiumei Zhou, Xiaoxin Wu, Lingxiao Jin, Xuhong Zhao, Qiaozhen Zhang, Junfeng Yin
    BMC Gastroenterology.2026;[Epub]     CrossRef
  • γ-Glutamylcysteine restores glucolipotoxicity-induced islet β-cell apoptosis and dysfunction via inhibiting endoplasmic reticulum stress
    Jinyi Zhou, Yingying Shi, Lishuang Zhao, Rong Wang, Lan Luo, Zhimin Yin
    Toxicology and Applied Pharmacology.2025; 495: 117206.     CrossRef
  • Comparison of SPISE and METS-IR and Other Markers to Predict Insulin Resistance and Elevated Liver Transaminases in Children and Adolescents
    Kyungchul Song, Eunju Lee, Hye Sun Lee, Hana Lee, Ji-Won Lee, Hyun Wook Chae, Yu-Jin Kwon
    Diabetes & Metabolism Journal.2025; 49(2): 264.     CrossRef
  • Unraveling the Mystery of Insulin Resistance: From Principle Mechanistic Insights and Consequences to Therapeutic Interventions
    Mohammad Muzaffar Mir, Mohammed Jeelani, Muffarah Hamid Alharthi, Syeda Fatima Rizvi, Shahzada Khalid Sohail, Javed Iqbal Wani, Zia Ul Sabah, Waad Fuad BinAfif, Partha Nandi, Abdullah M. Alshahrani, Jaber Alfaifi, Adnan Jehangir, Rashid Mir
    International Journal of Molecular Sciences.2025; 26(6): 2770.     CrossRef
  • Investigating the Effects of Gossypetin on Liver Health in Diet-Induced Pre-Diabetic Male Sprague Dawley Rats
    Karishma Naidoo, Andile Khathi
    Molecules.2025; 30(8): 1834.     CrossRef
  • Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study
    Ziping Song, Xinlei Miao, Shuang Liu, Manling Hu, Xiaoling Xie, Yuting Sun, Song Leng
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice
    Darya Ivashkevich, Arina Ponomarenko, Igor Manzhulo, Anastasia Egoraeva, Inessa Dyuizen
    Pathophysiology.2025; 32(2): 16.     CrossRef
  • Extracellular Vesicle-Mediated Network in the Pathogenesis of Obesity, Diabetes, Steatotic Liver Disease, and Cardiovascular Disease
    Joonyub Lee, Won Gun Choi, Marie Rhee, Seung-Hwan Lee
    Diabetes & Metabolism Journal.2025; 49(3): 348.     CrossRef
  • Association of cardiometabolic markers with hepatic steatosis and liver fibrosis in population without obesity and diabetes
    Zhixing Fan, Chaojun Yang, Xiaojing Zhao, Jing Zhang
    Scientific Reports.2025;[Epub]     CrossRef
  • The Triglyceride-Glucose Index and Risk of End-Stage Renal Disease across Different Durations of Type 2 Diabetes Mellitus: A Longitudinal Cohort Study
    Mi-sook Kim, Kyu-Na Lee, Jeongmin Lee, Jeongeun Kwak, Seung-Hwan Lee, Hyuk-Sang Kwon, Jing Hughes, Kyung-Do Han, Eun Young Lee
    Endocrinology and Metabolism.2025; 40(5): 718.     CrossRef
  • Tectoridin modulates intertwined molecular pathways in metabolic syndrome: insights from network pharmacology, molecular docking, and in vivo studies
    Ashwini Kumar Mishra, Pravat Kumar Sahoo, Rajesh Singh, Smita Jain
    Inflammopharmacology.2025; 33(9): 5545.     CrossRef
  • Triglyceride–Glucose-Based Anthropometric Indices for Predicting Incident Cardiovascular Disease: Relative Fat Mass (RFM) as a Robust Indicator
    Xinlei Chu, Haozhi Niu, Ning Wang, Yu Wang, Hongkai Xu, Huiying Wang, Liting Wu, Wei Li, Lei Han
    Nutrients.2025; 17(13): 2212.     CrossRef
  • Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality
    Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Associations between the effectiveness of sleeve gastrectomy and the composition and function of gut microbiome in obese rats
    Yifan Cao, Songhan Qin, Dandan Liu, Tao Zhang, Yin Wu, Ming Xie, Jiwei Wang
    Journal of Gastrointestinal Surgery.2025; 29(9): 102153.     CrossRef
  • Exercise Interventions for Metabolic Diseases: An Analysis of the Evolution of Aerobic Exercise Bibliometrics in the Field of Type 2 Diabetes Mellitus
    Yang Li, Amin Ullah, Shuhao Fang, Donglin Liu, Zhenwei Cui, Guangning Kou
    Healthcare.2025; 13(17): 2087.     CrossRef
  • Association Between Depression and Hepatic Steatosis According to Obese Status: The Korean National Health and Nutrition Examination Survey 2010–2019
    Young Sang Lyu, Youngmin Yoon, Jin Hwa Kim, Sang Yong Kim
    Medicina.2025; 61(9): 1711.     CrossRef
  • Serum Granulin Concentrations Are Elevated in Prediabetes and Newly Diagnosed Diabetes: A Cross-Sectional Study
    Yu-Hsuan Chou, Yuan Kao, Ka Chon Chan, Hsuan-Wen Chou, Yu-Cheng Liang, Hung-Tsung Wu, Horng-Yih Ou
    Journal of Clinical Medicine.2025; 14(18): 6566.     CrossRef
  • Mechanistic Insights into N-Oleoylethanolamide-Mediated Hepatoprotection via PPAR-α
    Darya Ivashkevich, Arina Ponomarenko, Igor Manzhulo, Inessa Dyuizen
    BIOCELL.2025; 49(4): 607.     CrossRef
  • Clinical Implementation of Sustainable Functional Foods and Nutraceuticals in Metabolic Health: A Feasibility Study
    Francesca Scionti, Samantha Maurotti, Elisa Mazza, Angela Mirarchi, Raffaella Russo, Paola Doria, Rosario Mare, Giuseppe Marafioti, Yvelise Ferro, Tiziana Montalcini, Arturo Pujia
    Nutrients.2025; 17(24): 3858.     CrossRef
  • The association of multiple metabolic disorders with the severity of fasting blood glucose and hepatic steatosis in a Chinese population with MAFLD: a cross-sectional study of over 3000 participants
    Xue Qu, Shanshan Jin, Yuqing Shi, Weisong Zhang, Delong Cong, Yangyang Liu
    Scientific Reports.2025;[Epub]     CrossRef
  • Frequency and Association of Dyslipidemia with Clinical and Biochemical Parameters among Patients with Non-alcoholic Fatty Liver Disease
    Arslan Ahmad, Shazia Siddique, Amanullah Bhalli, Amina Umer, Umayma Asad, Muhammad Irfan Jamil
    Pakistan Journal of Health Sciences.2025; : 75.     CrossRef
  • Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM rats
    Haoru Duan, Shanshan Song, Rui Li, Suqin Hu, Shuting Zhuang, Shaoyang liu, Xiaolu Li, Wei Gao
    Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
  • Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol-Young Park, Choon Hee Chung, Dae Ho Lee, Eun-Hee Cho, Eun-Jung Rhee, Ji Hee Yu, Ji Hyun Park, Ji-Cheol Bae, Jung Hwan Park, Kyung Mook Choi, Kyung-Soo Kim, Mi Hae Seo, Minyoung Lee, Nan-Hee Kim, So Hun Kim, Won-
    Diabetes & Metabolism Journal.2024; 48(6): 1015.     CrossRef
Review
Pathophysiology
Article image
Attention to Innate Circadian Rhythm and the Impact of Its Disruption on Diabetes
Da Young Lee, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Nan Hee Kim
Diabetes Metab J. 2024;48(1):37-52.   Published online January 3, 2024
DOI: https://doi.org/10.4093/dmj.2023.0193
  • 32,734 View
  • 759 Download
  • 17 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   ePub   
Novel strategies are required to reduce the risk of developing diabetes and/or clinical outcomes and complications of diabetes. In this regard, the role of the circadian system may be a potential candidate for the prevention of diabetes. We reviewed evidence from animal, clinical, and epidemiological studies linking the circadian system to various aspects of the pathophysiology and clinical outcomes of diabetes. The circadian clock governs genetic, metabolic, hormonal, and behavioral signals in anticipation of cyclic 24-hour events through interactions between a “central clock” in the suprachiasmatic nucleus and “peripheral clocks” in the whole body. Currently, circadian rhythmicity in humans can be subjectively or objectively assessed by measuring melatonin and glucocorticoid levels, core body temperature, peripheral blood, oral mucosa, hair follicles, rest-activity cycles, sleep diaries, and circadian chronotypes. In this review, we summarized various circadian misalignments, such as altered light-dark, sleep-wake, rest-activity, fasting-feeding, shift work, evening chronotype, and social jetlag, as well as mutations in clock genes that could contribute to the development of diabetes and poor glycemic status in patients with diabetes. Targeting critical components of the circadian system could deliver potential candidates for the treatment and prevention of type 2 diabetes mellitus in the future.

Citations

Citations to this article as recorded by  
  • Late-eating adolescents consume more energy, make poorer dietary choices, and are more likely to have excess weight: An analysis of the Brazilian Household Budget Survey (2008–2009)
    Maria Carliana Mota, Laura Cristina Tibiletti Balieiro, Luana Thomazetto Rossato, Claudia Roberta de Castro Moreno, Cibele Aparecida Crispim
    Chronobiology International.2026; 43(1): 104.     CrossRef
  • Unraveling the Tapestry of Health: The Intricate Dance of Circadian Rhythms and Human Diseases
    Sidrah Parvez, Andrej Dzupina, Ghizal Fatima, Najah Hadi, Jan Fedacko, Aminat Magomedova, Ammar Mehdi Raza, Nasser Ghaly Yousif, Hekmat B. Alhmadi
    Bratislava Medical Journal.2026; 127(2): 492.     CrossRef
  • Diabetes and its complications: molecular mechanisms, prevention and treatment
    Lijun Zhao, Jiamin Yuan, Qing Yang, Jing Ma, Fenghao Yang, Yutong Zou, Ke Liu, Fang Liu
    Signal Transduction and Targeted Therapy.2026;[Epub]     CrossRef
  • Prediabetes is a window of opportunity for preventive interventions. Part 2
    T. V. Adasheva, E. E. Gubernatorova, E. I. Fomina, E. G. Lobanova
    Meditsinskiy sovet = Medical Council.2026; (23): 123.     CrossRef
  • Association of daytime circadian-aligned activity with glycemic control in type 2 diabetes: Insights from continuous glucose monitoring and wearable data
    Da Young Lee, Jung-Been Lee, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Heon-Jeong Lee, Nan Hee Kim
    Metabolism.2026; 179: 156570.     CrossRef
  • Applying AI Tools for Monitoring Nutrition and Physical Activity in Populations with Obesity: Are We Ready?
    Alessandra Amato, Sara Baldassano, Giuseppe Musumeci
    Obesities.2026; 6(2): 19.     CrossRef
  • PERSONALIZED CHRONOTHERAPY: BRIDGING PRECISION MEDICINE WITH CIRCADIAN THERAPEUTICS
    Rajeswari Aleti, Monika Nijhawan, Mohammad Bakhatwar, Srinivas Baratam, Krishna Kishore Adireddy
    INDIAN DRUGS.2026; 63(03): 8.     CrossRef
  • Humidity as a potential zeitgeber for circadian entrainment of insect systems
    Shyh-Chi Chen, Grace Goodhart, Daniel Eaton, Nathan Catlett, Tabitha Cady, Hannah Tran, Luke E. Lutz, Lyn Wang, Ella Girard, Jaida Savino, Jodi Perry, Libby Coen, Leo Walker, Amena Bidiwala, Emma Tarter, Joshua Tompkin, Nina Greene, Aiden Yang, Joshua B.
    npj Biological Timing and Sleep.2026;[Epub]     CrossRef
  • Management of Obstructive Sleep Apnea in People with Type 2 Diabetes
    Niel Patel, Miriam Soliman, Amit Majithia, Atul Malhotra
    Diabetology.2026; 7(7): 128.     CrossRef
  • Diversity of Daily Glycemic Phenotypes Is Independently Associated With HbA1c: A Time-Resolved CGM Clustering Analysis
    Saeko Osawa, Emi Kuroiwa, Naohiko Ito
    Journal of Diabetes Science and Technology.2026;[Epub]     CrossRef
  • Circadian Misalignment and Chrononutrition in Type 2 Diabetes: Mechanistic Insights and Translational Gaps
    İsmail Celil Haskoloğlu, Zeynep Güneş Özünal
    International Journal of Molecular Sciences.2026; 27(19): 8473.     CrossRef
  • Chrononutrition: Potential, Challenges, and Application in Managing Obesity
    Siti Aisyah Fuad, Rehna Paula Ginting, Min-Woo Lee
    International Journal of Molecular Sciences.2025; 26(11): 5116.     CrossRef
  • Chrononutrition and Energy Balance: How Meal Timing and Circadian Rhythms Shape Weight Regulation and Metabolic Health
    Claudia Reytor-González, Daniel Simancas-Racines, Náthaly Mercedes Román-Galeano, Giuseppe Annunziata, Martina Galasso, Raynier Zambrano-Villacres, Ludovica Verde, Giovanna Muscogiuri, Evelyn Frias-Toral, Luigi Barrea
    Nutrients.2025; 17(13): 2135.     CrossRef
  • Chronic stress, gut microbiota, and immunity: interconnections and implications for health
    Hexiao Jia, Xiaodong Guo, Yihong Wei, Can Can, Na He, Hailei Zhang, Xinyu Yang, Hanyang Wu, Wancheng Liu, Daoxin Ma
    Molecular and Cellular Biochemistry.2025; 480(12): 5995.     CrossRef
  • Chrononutrition and sleep patterns in individuals with diabetes mellitus: Assessing misalignments and social jetlag
    Micaela Rabelo Quadra, Fernanda Olivera Meller, Antônio Augusto Schäfer, Taísa Dimer Hendler, Emilio Luiz Streck
    Chronobiology International.2025; 42(10): 1427.     CrossRef
  • Effects of time-restricted eating on body composition and metabolic parameters in overweight and obese women: a systematic review and meta-analysis
    Shiying Chen, Xiaotian Zhang, Jakub Kortas, Haitao Liu
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • The oncogenic role of BMAL2 in non-small cell lung cancer: MRPL15-mediated regulation of apoptosis and ferroptosis
    Yang Liu, Yixia Li, Xiaotian Zhai, Lei Yang, Jie Li, Yi Han
    Translational Oncology.2025; 62: 102560.     CrossRef
  • Circadian Rhythm: Biological Functions, Diseases, and Therapeutic Targets
    Kangkang Zha, Bobin Mi, Yuan Xiong, Shuyan Wu, Li Lu, Shengming Zhang, Xuan Lu, Hei Chung Mak, Jianping Huang, Adriana C. Panayi, Samuel Knoedler, Lili Chen, Guohui Liu, Sien Lin
    MedComm.2025;[Epub]     CrossRef
Original Articles
Technology/Device
Article image
Clinical and Lifestyle Determinants of Continuous Glucose Monitoring Metrics in Insulin-Treated Patients with Type 2 Diabetes Mellitus
Da Young Lee, Namho Kim, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Jihee Kim, Kyeong Jin Kim, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Sung-Min Park, Nan Hee Kim
Diabetes Metab J. 2023;47(6):826-836.   Published online August 24, 2023
DOI: https://doi.org/10.4093/dmj.2022.0273
  • 11,971 View
  • 305 Download
  • 6 Web of Science
  • 6 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
There was limited evidence to evaluate the association between lifestyle habits and continuous glucose monitoring (CGM) metrics. Thus, we aimed to depict the behavioral and metabolic determinants of CGM metrics in insulin-treated patients with type 2 diabetes mellitus (T2DM).
Methods
This is a prospective observational study. We analyzed data from 122 insulin-treated patients with T2DM. Participants wore Dexcom G6 and Fitbit, and diet information was identified for 10 days. Multivariate-adjusted logistic regression analysis was performed for the simultaneous achievement of CGM-based targets, defined by the percentage of time in terms of hyper, hypoglycemia and glycemic variability (GV). Intake of macronutrients and fiber, step counts, sleep, postprandial C-peptide-to-glucose ratio (PCGR), information about glucose lowering medications and metabolic factors were added to the analyses. Additionally, we evaluated the impact of the distribution of energy and macronutrient during a day, and snack consumption on CGM metrics.
Results
Logistic regression analysis revealed that female, participants with high PCGR, low glycosylated hemoglobin (HbA1c) and daytime step count had a higher probability of achieving all targets based on CGM (odds ratios [95% confidence intervals] which were 0.24 [0.09 to 0.65], 1.34 [1.03 to 1.25], 0.95 [0.9 to 0.99], and 1.15 [1.03 to 1.29], respectively). And participants who ate snacks showed a shorter period of hyperglycemia and less GV compared to those without.
Conclusion
We confirmed that residual insulin secretion, daytime step count, HbA1c, and women were the most relevant determinants of adequate glycemic control in insulin-treated patients with T2DM. In addition, individuals with snack consumption were exposed to lower times of hyperglycemia and GV.

Citations

Citations to this article as recorded by  
  • Utility of continuous glucose monitoring in people with type 2 diabetes on insulin-based regimens in clinical practice: A case series and expert opinion
    Soo Lim, Rimei Nishimura, Jothydev Kesavadev, Alice Pik Shan Kong, Margaret J McGill, Horng-Yih Ou, Chun-Kwan O, Chun-Chuan Lee, Xiaomei Zhang, Linong Ji, Chih-Yuan Wang
    Diabetes Research and Clinical Practice.2026; 233: 113054.     CrossRef
  • Association of daytime circadian-aligned activity with glycemic control in type 2 diabetes: Insights from continuous glucose monitoring and wearable data
    Da Young Lee, Jung-Been Lee, Inha Jung, So Young Park, Ji Hee Yu, Ji A Seo, Heon-Jeong Lee, Nan Hee Kim
    Metabolism.2026; 179: 156570.     CrossRef
  • Accelerometer-Derived Physical Activity, Sedentary Behavior, and Continuous Glucose Monitoring-Derived Glycemic Variability in Adults with Type 2 Diabetes: A Longitudinal Repeated-Measures Study
    Paul César Velásquez Porras, Alicia Olinda Neyra Aranda, Dimna Zoila Alfaro Quezada, Digmer Pablo Riquez Livia, Henri Emmanuel Lopez Gomez, Roberto Carlos Dávila-Morán
    Journal of Functional Morphology and Kinesiology.2026; 11(3): 338.     CrossRef
  • Clinical, genetic, and proteomic characteristics of type 2 diabetes complicated with exogenous insulin antibody syndrome: a case-control study
    Jinjing Wan, Leiluo Geng, Yiwen Fu, Qianting Zhang, Gaopeng Guan, Xue Jiang, Aimin Xu, Ping Jin
    Diabetes Research and Clinical Practice.2025; 225: 112262.     CrossRef
  • Expanding the Use of Continuous Glucose Monitoring in Type 2 Diabetes Mellitus: Impact on Glycemic Control and Metabolic Health
    Mi-Joon Lee, Bum-Jeun Seo, Jae-Hyoung Cho
    Life.2025; 15(10): 1543.     CrossRef
  • Explanatory variables of objectively measured 24-h movement behaviors in people with prediabetes and type 2 diabetes: A systematic review
    Lotte Bogaert, Iris Willems, Patrick Calders, Eveline Dirinck, Manon Kinaupenne, Marga Decraene, Bruno Lapauw, Boyd Strumane, Margot Van Daele, Vera Verbestel, Marieke De Craemer
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2024; 18(4): 102995.     CrossRef
Lifestyle
Article image
Changes in Patterns of Physical Activity and Risk of Heart Failure in Newly Diagnosed Diabetes Mellitus Patients
Inha Jung, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Eun-Jung Rhee, Won-Young Lee
Diabetes Metab J. 2022;46(2):327-336.   Published online November 24, 2021
DOI: https://doi.org/10.4093/dmj.2021.0046
  • 11,980 View
  • 270 Download
  • 14 Web of Science
  • 16 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Exercise is recommended for type 2 diabetes mellitus (T2DM) patients to prevent cardiovascular disease. However, the effects of physical activity (PA) for reducing the risk of heart failure (HF) has yet to be elucidated. We aimed to assess the effect of changes in patterns of PA on incident HF, especially in newly diagnosed diabetic patients.
Methods
We examined health examination data and claims records of 294,528 participants from the Korean National Health Insurance Service who underwent health examinations between 2009 and 2012 and were newly diagnosed with T2DM. Participants were classified into the four groups according to changes in PA between before and after the diagnosis of T2DM: continuously inactive, inactive to active, active to inactive, and continuously active. The development of HF was analyzed until 2017.
Results
As compared with those who were continuously inactive, those who became physically active after diagnosis showed a reduced risk for HF (adjusted hazard ratio [aHR], 0.79; 95% confidence interval [CI], 0.66 to 0.93). Those who were continuously active had the lowest risk for HF (aHR, 0.77; 95% CI, 0.62 to 0.96). As compared with those who were inactive, those who exercised regularly, either performing vigorous or moderate PA, had a lower HF risk (aHR, 0.79; 95% CI, 0.69 to 0.91).
Conclusion
Among individuals with newly diagnosed T2DM, the risk of HF was reduced in those with higher levels of PA after diagnosis was made. Our results suggest either increasing or maintaining the frequency of PA after the diagnosis of T2DM may lower the risk of HF.

Citations

Citations to this article as recorded by  
  • Global, regional, and national burden of major diabetes-related complications attributable to physical inactivity
    Jayne Feter, Natan Feter, Rodrigo Leal-Menezes, Pedro C. Hallal, Daniel Umpierre
    Journal of Sport and Health Science.2026; 15: 101123.     CrossRef
  • Does physical activity reduce cardiovascular risk associated with knee osteoarthritis in type 2 diabetes? A nationwide cohort study
    Dojoon Park, Kyuho Kim, Hae-Seok Koh, Kyungdo Han, Youn-Ho Choi
    The Korean Journal of Internal Medicine.2026; 41(3): 485.     CrossRef
  • 2026 ESC Guidelines for the management of heart failure
    Lars Køber, Marianna Adamo, Anne-Christine Ruwald, Daniela Tomasoni, Lisa J Anderson, Charlotte Andersson, Jasper J Brugts, Ovidiu Chioncel, Erwan Donal, Peter Ferdinandy, Pardeep S Jhund, Francisco Leyva, Roberto Lorusso, Michael Madigan, Wilfried Mullen
    European Heart Journal.2026; 47(38): 5346.     CrossRef
  • Life-course obesity and heart failure: a two-sample Mendelian randomization study
    Haili Wang, Jie Min, Lei Zhong, Jinyu Zhang, Lili Ye, Chunrong Chen
    Internal and Emergency Medicine.2025; 20(1): 171.     CrossRef
  • Critical Appraisal of Pharmaceutical Therapy in Diabetic Cardiomyopathy—Challenges and Prospectives
    Elina Khattab, Michaelia Kyriakou, Elena Leonidou, Stefanos Sokratous, Angeliki Mouzarou, Michael M. Myrianthefs, Nikolaos P. E. Kadoglou
    Pharmaceuticals.2025; 18(1): 134.     CrossRef
  • Sitagliptin, diabetes mellitus, and heart failure: an in-depth review of sitagliptin therapy and heart failure in patients with diabetes mellitus
    Mohammadjavad Sotoudeheian, Seyed-Mohamad-Sadegh Mirahmadi, Pedram Salehi Darjani, Mohammad Moradi, Mohammad Pirhayati, Mohammad Sedigh Dakkali, Mehdi Taghizadeh, Reza Azarbad, Hamidreza Pazoki Toroudi
    Diabetology International.2025; 16(2): 237.     CrossRef
  • Exploring the Lack of Physical Activity among Adolescents Worldwide
    Dalmacito A. Cordero Jr.
    Diabetes & Metabolism Journal.2025; 49(3): 513.     CrossRef
  • Physical activity for prevention of cardiovascular disease: consensus statement of Korean Society of Cardio-cerebrovascular Disease Prevention
    Ye Seul Yang, Eu Jeong Ku, Seung-Hyun Ko, Eun-Jung Rhee, Sang-Hyun Ihm, Sung Hee Choi, Won-Young Lee
    The Korean Journal of Internal Medicine.2025; 40(5): 696.     CrossRef
  • Physical activity for prevention of cardiovascular disease: a consensus statement of the Korean Society of Cardio-cerebrovascular Disease Prevention
    Ye Seul Yang, Eu Jeong Ku, Seung-Hyun Ko, Eun-Jung Rhee, Sang-Hyun Ihm, Sung Hee Choi, Won-Young Lee
    Cardiovascular Prevention and Pharmacotherapy.2025; 7(4): 120.     CrossRef
  • Associations Between Physical Activity and the Risk of Hip Fracture Depending on Glycemic Status: A Nationwide Cohort Study
    Kyoung Min Kim, Kyoung Jin Kim, Kyungdo Han, Yumie Rhee
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(3): e1194.     CrossRef
  • Association between exercise habits and incident type 2 diabetes mellitus in patients with thyroid cancer: nationwide population-based study
    Jiyun Park, Jin-Hyung Jung, Hyunju Park, Young Shin Song, Soo-Kyung Kim, Yong-Wook Cho, Kyungdo Han, Kyung-Soo Kim
    BMC Medicine.2024;[Epub]     CrossRef
  • Dose-Response Relationship Between Physical Activity and the Morbidity and Mortality of Cardiovascular Disease Among Individuals With Diabetes: Meta-Analysis of Prospective Cohort Studies
    Yang Chen, Xingsheng Jin, Guochong Chen, Ru Wang, Haili Tian
    JMIR Public Health and Surveillance.2024; 10: e54318.     CrossRef
  • Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
    Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
    International Journal of Heart Failure.2023; 5(1): 1.     CrossRef
  • Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
    Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
    Diabetes & Metabolism Journal.2023; 47(1): 10.     CrossRef
  • Association of plasma brain-derived neurotrophic factor levels and frailty in community-dwelling older adults
    Eun Roh, Soon Young Hwang, Eyun Song, Min Jeong Park, Hye Jin Yoo, Sei Hyun Baik, Miji Kim, Chang Won Won, Kyung Mook Choi
    Scientific Reports.2022;[Epub]     CrossRef
  • The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study
    Jiyun Park, Gyuri Kim, Hasung Kim, Jungkuk Lee, Sang-Man Jin, Jae Hyeon Kim
    Cardiovascular Diabetology.2022;[Epub]     CrossRef
Review
Technology/Device
Article image
Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence
Sun Joon Moon, Inha Jung, Cheol-Young Park
Diabetes Metab J. 2021;45(6):813-839.   Published online November 22, 2021
DOI: https://doi.org/10.4093/dmj.2021.0177
  • 42,673 View
  • 1,254 Download
  • 77 Web of Science
  • 79 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Since Banting and Best isolated insulin in the 1920s, dramatic progress has been made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely injection to maintain optimal glycemic control are often challenging for T1DM patients and their families because they require frequent blood glucose checks. In recent years, technological advances in insulin pumps and continuous glucose monitoring systems have created paradigm shifts in T1DM care that are being extended to develop artificial pancreas systems (APSs). Numerous studies that demonstrate the superiority of glycemic control offered by APSs over those offered by conventional treatment are still being published, and rapid commercialization and use in actual practice have already begun. Given this rapid development, keeping up with the latest knowledge in an organized way is confusing for both patients and medical staff. Herein, we explore the history, clinical evidence, and current state of APSs, focusing on various development groups and the commercialization status. We also discuss APS development in groups outside the usual T1DM patients and the administration of adjunct agents, such as amylin analogues, in APSs.

Citations

Citations to this article as recorded by  
  • Unlocking Real-Time Data Access in Diabetes Management: Toward an Interoperability Model
    Pietro Randine, Miriam Kopperstad Wolff, Matthias Pocs, Ian R. O. Connell, Joseph A. Cafazzo, Eirik Årsand
    Journal of Diabetes Science and Technology.2026; 20(5): 1565.     CrossRef
  • Real-World Outcomes of Hybrid Closed-Loop System Use in Korean Youth With Childhood-Onset Type 1 Diabetes
    Hyun Ah Woo, Su Jin Jeong, Yun Jeong Lee, Hwa Young Kim, Minjeong Gu, Ji Young Kim, Jaehyun Kim, Choong Ho Shin, Young Ah Lee
    Journal of Korean Medical Science.2026;[Epub]     CrossRef
  • Neuromodulation using Bioelectronics-enabled therapies to combat insulin resistance and its comorbidities
    Yosra Magdi Mekki, Jeongeun Park, Zeinah Alzaareer, Zaeem Hussain, Ayesha Gulzar, Abdelnaser Elzouki, Amparo Güemes, Susu M. Zughaier
    Journal of Diabetes & Metabolic Disorders.2026;[Epub]     CrossRef
  • Computational physiological models for hemodynamic management in critical care: a systematic literature review focusing on model design, credibility and clinical readiness
    M.P. Mulder, R.S.P. Warnaar, T.F. Arendshorst-Ruuls, L.M. van Loon, C.L. Meuwese, M. Broomé, E. Oppersma, D.W. Donker, L. Fresiello
    Computers in Biology and Medicine.2026; 205: 111561.     CrossRef
  • Automated insulin delivery in young children with type 1 diabetes: a systematic review and meta-analysis
    Puguh Oktavian, Citrawati Dyah Kencono Wungu, Indah Mohd Amin, Sony Wibisono Mudjanarko
    The Journal of Clinical Endocrinology & Metabolism.2026; 111(8): e2043.     CrossRef
  • GluPatchNet: A Channel-Mixed and decomposition-based blood glucose prediction scheme for mitigating CGM time delay
    Su-Jin Kim, Sungho Kim, Jun Sung Moon, Sung-Yoon Jung
    ICT Express.2026; 12(3): 746.     CrossRef
  • Pancreas transplantation: Radiological assessment of surgical techniques and potential complications
    A. Berasategui Criado, S. Cayón Somacarrera, R. Pellón Daben, F.J. González Sánchez, J.A. Echeverri Cifuentes, J. Crespo del Pozo
    Radiología (English Edition).2026; : 501696.     CrossRef
  • To be, or not to be, on insulin for simultaneous kidney-pancreas transplant: Is that the question?
    Robert J. Stratta, Alan C. Farney, Jonathan A. Fridell
    American Journal of Transplantation.2026;[Epub]     CrossRef
  • Metabolic Responses to Exercise and Nutritional Strategies in Type 1 Diabetes Using Automated Insulin Delivery Systems: A Narrative Review
    Desirée Victoria-Montesinos, Inmaculada Llopis-Alonso, Ana María García-Muñoz, María Teresa Mercader-Ros
    Metabolites.2026; 16(7): 437.     CrossRef
  • Long-term effectiveness of automated insulin delivery in young people with type 1 diabetes: a meta-analysis
    Zhihui Sun, Sihan Yang, Le Gao, Lin Dou, Baoqi Zeng
    Diabetology & Metabolic Syndrome.2026;[Epub]     CrossRef
  • Artificial intelligence in medicine: a clinician-oriented guide and operational framework to evaluate new AI devices
    Gabriel Szydlo Shein, Serban C. Tudosie, Stefan M. Jensen, Ronit Brodie, Sylvain Lecler, Michele Diana, Yoav Mintz
    Minimally Invasive Therapy & Allied Technologies.2026; : 1.     CrossRef
  • Artificial Pancreas and Closed-Loop Insulin Delivery: From Early Concepts to AI-Driven Diabetes Automation
    Reem Emad Al-Dhaleai, Mustafa Tariq Khan, Zaid Chilmeran, Abdulrahman Husain AlSadeq, Alexandra E. Butler
    Biosensors.2026; 16(9): 507.     CrossRef
  • Smart Pharmaceutical Systems: Sensor-Enabled Delivery, Feedback Control, and Therapeutic Autonomy
    Ahmed Benali, Karim Boudiaf, Samir Touati
    Journal of Applied Pharmaceutical Technologies and Systems.2026;[Epub]     CrossRef
  • Implantable Fluorogenic DNA Biosensor for Stress Detection
    Irina Drachuk, Namrata Ramani, Svetlana Harbaugh, Chad A. Mirkin, Jorge L. Chávez
    ACS Applied Materials & Interfaces.2025; 17(1): 130.     CrossRef
  • CHoKI-based MPC for blood glucose regulation in Artificial Pancreas
    Beatrice Sonzogni, José María Manzano, Marco Polver, Fabio Previdi, Antonio Ferramosca
    IFAC Journal of Systems and Control.2025; 31: 100294.     CrossRef
  • Automated insulin delivery in pregnant women with type 1 diabetes: a systematic review and meta-analysis
    Qin Yang, Jiayi Hao, Huijing Cui, Qingqing Yang, Feng Sun, Baoqi Zeng
    Acta Diabetologica.2025; 62(8): 1325.     CrossRef
  • Designing and developing a prescription digital therapeutic for at-home heart rate variability biofeedback to support and enhance patient outcomes in post-traumatic stress disorder treatment
    Rebecca Macy, Flavio Somanji, Oleksandr Sverdlov
    Frontiers in Digital Health.2025;[Epub]     CrossRef
  • Generalized reinforcement learning control algorithm for fully automated insulin delivery system
    Vega Pradana Rachim, Junyoung Yoo, Jaeyeon Lee, Yein Lee, Sung-Min Park
    Expert Systems with Applications.2025; 274: 126909.     CrossRef
  • Allogeneic Islet Transplantation: Chronicle of a Death Foretold?
    Thierry Berney, Olivier Thaunat, Ekaterine Berishvili
    Transplant International.2025;[Epub]     CrossRef
  • Exogenous vs Endogenous Insulin Delivery: 2025
    Ankita Patel, Rachel Todd, Nina L. Owen-Simon, Kasi McCune
    Current Transplantation Reports.2025;[Epub]     CrossRef
  • Long-term blood glucose prediction using deep learning-based noise reduction
    Su-Jin Kim, Jun Sung Moon, Sung-Yoon Jung
    ICT Express.2025; 11(4): 715.     CrossRef
  • Trasplante de páncreas: evaluación radiológica de las técnicas quirúrgicas y potenciales complicaciones
    A. Berasategui Criado, S. Cayón Somacarrera, R. Pellón Daben, F.J. González Sánchez, J.A. Echeverri Cifuentes, J. Crespo del Pozo
    Radiología.2025; : 501696.     CrossRef
  • Nano-based therapy for type 1 diabetes: from immuno-intervention to insulin delivery
    Huiwen Pang, Zhuo Chen, Felicity Y. Han
    Acta Biomaterialia.2025; 201: 101.     CrossRef
  • Real-world evaluation of safety and efficacy of AHCL systems in young children with type 1 diabetes: a 1-year assessment
    Daniele Franzone, Giordano Spacco, Andrea Piano, Giulia Siri, Giacomo Tantari, Giuseppe d’Annunzio, Maria Grazia Calevo, Mohamad Maghnie, Nicola Minuto, Marta Bassi
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Artificial Pancreas: The First 20 Years
    Francis J. Doyle, Boris P. Kovatchev
    Journal of Diabetes Science and Technology.2025; 19(4): 875.     CrossRef
  • Artificial Pancreas: The First 20 Years*
    Francis J. Doyle, Boris P. Kovatchev
    Diabetes Technology & Therapeutics.2025;[Epub]     CrossRef
  • Optimal model-based insulin bolus advisor for subjects with type 1 diabetes using continuous glucose monitoring
    Martin Dodek, Eva Miklovičová
    Computers in Biology and Medicine.2025; 196: 110508.     CrossRef
  • Advancements of Glucose Monitoring Biosensor: Current State, Generations of Technological Progress and Innovation Dynamics
    Arpita Dua, Abhijit Debnath, Kunal Kumar, Rupa Mazumder, Avijit Mazumder, Rajesh Kumar Singh, Saloni Mangal, Jahanvi Sanchitra, Fahad Khan, Soumya Tripathi, Sukriti Vishwas, Hema Chaudhary, Parul Sharma, Shikha Srivastava
    Current Pharmaceutical Biotechnology.2025; 26(11): 1716.     CrossRef
  • Dual hormone predictive control for a fully automated intraperitoneal artificial pancreas: Preclinical evaluation in pigs
    Karim Davari Benam, Hasti Khoshamadi, Marte Kierulf Å m, Sverre Chr. Christiansen, Patrick Christian Bösch, Dag Roar Hjelme, Øyvind Stavdahl, Sven Magnus Carlsen, Sébastien Gros, Anders Lyngvi Fougner
    Journal of Process Control.2025; 154: 103499.     CrossRef
  • Artificial Intelligence in Patient Management
    Nicholas Conley
    Primary Care: Clinics in Office Practice.2025; 52(4): 733.     CrossRef
  • Current Status of Continuous Glucose Monitoring Use in South Korean Type 1 Diabetes Mellitus Population–Pronounced Age-Related Disparities: Nationwide Cohort Study
    Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2025; 49(5): 1040.     CrossRef
  • Multimodal large language models and mechanistic modeling for glucose forecasting in type 1 diabetes patients
    J.C. Wolber, M. E. Samadi, J. Sellin, A. Schuppert
    Journal of Biomedical Informatics.2025; 172: 104945.     CrossRef
  • Effectiveness and safety of automated insulin delivery in type 2 diabetes: a meta-analysis
    Baoqi Zeng, Hao Jia, Sihan Yang, Jiaming Zheng, Qingqing Yang, Lin Dou
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • The differential impact of automated insulin delivery systems on body mass index in children with type 1 diabetes
    John Pemberton, Catarina Leal, Anjanee Kohli, Lesley Drummond, Louise Collins, Zainaba Mohamed, Vrinda Saraff, Renuka P. Dias, Melanie Kershaw, Ruth Krone, Suma Uday
    Journal of Pediatric Endocrinology and Metabolism.2025; 38(12): 1258.     CrossRef
  • Dispositivi indossabili per la gestione del diabete
    Filippo CARLUCCI, Antonella TABUCCHI, Marcello FIORINI, Lucrezia GALASSO, Alessandro TERRENI
    Biochimica Clinica.2025;[Epub]     CrossRef
  • Integration of a Safety Module to Prevent Rebound Hypoglycemia in Closed-Loop Artificial Pancreas Systems
    María F. Villa-Tamayo, Patricio Colmegna, Marc D. Breton
    Journal of Diabetes Science and Technology.2024; 18(2): 318.     CrossRef
  • The effects of acute hyperglycaemia on sports and exercise performance in type 1 diabetes: A systematic review and meta-analysis
    Bonar McGuire, Hashim Dadah, Dominic Oliver
    Journal of Science and Medicine in Sport.2024; 27(2): 78.     CrossRef
  • A new approach to stabilize diabetes systems with time-varying delays and disturbance rejection
    S. Syafiie, Fahd Alharbi, Abdullah Ali Alshehri, Bassam Hasanain
    Journal of the Franklin Institute.2024; 361(1): 543.     CrossRef
  • Effects of Low-Dose Glucagon on Subcutaneous Insulin Absorption in Pigs
    Ingrid Anna Teigen, Marte Kierulf Åm, Misbah Riaz, Sverre Christian Christiansen, Sven Magnus Carlsen
    Current Therapeutic Research.2024; 100: 100736.     CrossRef
  • Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes
    John Pemberton, Louise Collins, Lesley Drummond, Renuka P Dias, Ruth Krone, Melanie Kershaw, Suma Uday
    BMJ Open Diabetes Research & Care.2024; 12(3): e004045.     CrossRef
  • Robust Online Correlation Method for Identification of a Nonparametric Model of Type 1 Diabetes
    Martin Dodek, Eva Miklovičová
    IEEE Access.2024; 12: 35899.     CrossRef
  • Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
    Ji Yoon Kim, Sang-Man Jin, Eun Seok Kang, Soo Heon Kwak, Yeoree Yang, Jee Hee Yoo, Jae Hyun Bae, Jun Sung Moon, Chang Hee Jung, Ji Cheol Bae, Sunghwan Suh, Sun Joon Moon, Sun Ok Song, Suk Chon, Jae Hyeon Kim
    Diabetologia.2024; 67(7): 1235.     CrossRef
  • Prevention and treatment of type 1 diabetes: in search of the ideal combination therapy targeting multiple immunometabolic pathways
    Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Maria Luisa Garo, Donatella Pastore, Francesca Pacifici, Camillo Ricordi, David Della-Morte, Marco Infante
    Metabolism and Target Organ Damage.2024;[Epub]     CrossRef
  • Mitigating diabetes associated with reactive oxygen species (ROS) and protein aggregation through pharmacological interventions
    Giulia Bennici, Hanan Almahasheer, Mawadda Alghrably, Daniela Valensin, Arian Kola, Chrysoula Kokotidou, Joanna Lachowicz, Mariusz Jaremko
    RSC Advances.2024; 14(25): 17448.     CrossRef
  • Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis
    Qin Yang, Baoqi Zeng, Jiayi Hao, Qingqing Yang, Feng Sun
    Diabetes, Obesity and Metabolism.2024; 26(9): 3753.     CrossRef
  • Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study
    Marta Bassi, Daniele Franzone, Francesca Dufour, Giordano Spacco, Federico Cresta, Giuseppe d’Annunzio, Giacomo Tantari, Maria Grazia Calevo, Carlo Castellani, Nicola Minuto, Rosaria Casciaro
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Emerging Technologies in Endocrine Drug Delivery: Innovations for Improved Patient Care
    Mahvish Renzu, Carly Hubers, Kendall Conway, Viktoriya Gibatova, Vidhi Mehta, Wael Taha
    Cureus.2024;[Epub]     CrossRef
  • A stochastic model-based control methodology for glycemic management in the intensive care unit
    Melike Sirlanci, George Hripcsak, Cecilia C. Low Wang, J. N. Stroh, Yanran Wang, Tellen D. Bennett, Andrew M. Stuart, David J. Albers
    Frontiers in Medical Engineering.2024;[Epub]     CrossRef
  • Advances in Type 1 Diabetes Mellitus Management in Children
    Mridu Bahal, Vineeta Pande, Jasleen Dua, Shailaja Mane
    Cureus.2024;[Epub]     CrossRef
  • Expansion of the Pancreas Transplant Recipient Pool: Appropriate for Most or Are There Limits?
    Jonathan A. Fridell, Robert J. Stratta
    Current Transplantation Reports.2024; 11(4): 276.     CrossRef
  • Reinforcement Learning: A Paradigm Shift in Personalized Blood Glucose Management for Diabetes
    Lehel Dénes-Fazakas, László Szilágyi, Levente Kovács, Andrea De Gaetano, György Eigner
    Biomedicines.2024; 12(9): 2143.     CrossRef
  • Diabetes Management: Herbal Remedies and Emerging Therapies
    Pratik Kumar Vishwakarma, Ankita Moharana, Snigdha Rani Behra, Priyabati Choudhury, Sonali Jayronia, Shivendra Mani Tripathi
    Current Nutraceuticals.2024;[Epub]     CrossRef
  • Impact of Hypoglycemia on Glucose Variability over Time for Individuals with Open-Source Automated Insulin Delivery Systems
    Arsalan Shahid, Dana M. Lewis
    Diabetology.2024; 5(5): 514.     CrossRef
  • Optimal model-based insulin dosing strategy with offline and online optimization
    Martin Dodek, Eva Miklovičová, Miroslav Halás
    Informatics in Medicine Unlocked.2024; 51: 101594.     CrossRef
  • Technological advancements in glucose monitoring and artificial pancreas systems for shaping diabetes care
    Neha Ghosh, Saurabh Verma
    Current Medical Research and Opinion.2024; 40(12): 2095.     CrossRef
  • A novel pulse-modulated closed-loop artificial pancreas based on intravenous administration of insulin and glucagon
    Simon L. Goede, Victor H. Snels, Willem-Jan W. J. H. Berghuis, Jan P. C. Bernards, Urs Wyder
    Scientific Reports.2024;[Epub]     CrossRef
  • 100 Years of insulin: A chemical engineering perspective
    B. Wayne Bequette
    Korean Journal of Chemical Engineering.2023; 40(1): 1.     CrossRef
  • Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial
    Sun Joon Moon, Kyung‐Soo Kim, Woo Je Lee, Mi Yeon Lee, Robert Vigersky, Cheol‐Young Park
    Diabetes, Obesity and Metabolism.2023; 25(1): 110.     CrossRef
  • Identifiable prediction animal model for the bi-hormonal intraperitoneal artificial pancreas
    Karim Davari Benam, Hasti Khoshamadi, Marte Kierulf Åm, Øyvind Stavdahl, Sebastien Gros, Anders Lyngvi Fougner
    Journal of Process Control.2023; 121: 13.     CrossRef
  • Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control
    Jee Hee Yoo, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2023; 47(1): 27.     CrossRef
  • CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review
    John S Pemberton, Emma G Wilmot, Katharine Barnard‐Kelly, Lalantha Leelarathna, Nick Oliver, Tabitha Randell, Craig E Taplin, Pratik Choudhary, Peter Adolfsson
    Diabetes, Obesity and Metabolism.2023; 25(4): 916.     CrossRef
  • Evaluation of awareness and attitude of paediatric nursing students, nurses, and adolescents regarding type one diabetes advanced devices and virtual nursing
    Howaida Moawad Ahmed Ali
    Kontakt.2023; 25(2): 100.     CrossRef
  • Predicting the output error of the suboptimal state estimator to improve the performance of the MPC-based artificial pancreas
    Martin Dodek, Eva Miklovičová
    Control Theory and Technology.2023; 21(4): 541.     CrossRef
  • A Markov Model of Gap Occurrence in Continuous Glucose Monitoring Data for Realistic in Silico Clinical Trials
    Martina Vettoretti, Martina Drecogna, Simone Del Favero, Andrea Facchinetti, Giovanni Sparacino
    Computer Methods and Programs in Biomedicine.2023; 240: 107700.     CrossRef
  • Drug delivery breakthrough technologies – A perspective on clinical and societal impact
    Beate Bittner, Manuel Sánchez-Félix, Dennis Lee, Athanas Koynov, Joshua Horvath, Felix Schumacher, Simon Matoori
    Journal of Controlled Release.2023; 360: 335.     CrossRef
  • Importance of continuous glucose monitoring in the treatment of diabetes mellitus
    Sun Joon Moon, Won-Young Lee
    Journal of the Korean Medical Association.2023; 66(7): 432.     CrossRef
  • Constrained Versus Unconstrained Model Predictive Control for Artificial Pancreas
    Chiara Toffanin, Lalo Magni
    IEEE Transactions on Control Systems Technology.2023; 31(5): 2288.     CrossRef
  • Intelligent Insulin vs. Artificial Intelligence for Type 1 Diabetes: Will the Real Winner Please Stand Up?
    Valentina Maria Cambuli, Marco Giorgio Baroni
    International Journal of Molecular Sciences.2023; 24(17): 13139.     CrossRef
  • Artificial Intelligence in Efficient Diabetes Care
    Gopal Bhagwan Khodve, Sugato Banerjee
    Current Diabetes Reviews.2023;[Epub]     CrossRef
  • The artificial pancreas: two alternative approaches to achieve a fully closed-loop system with optimal glucose control
    M. K. Åm, I. A. Teigen, M. Riaz, A. L. Fougner, S. C. Christiansen, S. M. Carlsen
    Journal of Endocrinological Investigation.2023; 47(3): 513.     CrossRef
  • Multivariable Automated Insulin Delivery System for Handling Planned and Spontaneous Physical Activities
    Mohammad Reza Askari, Mohammad Ahmadasas, Andrew Shahidehpour, Mudassir Rashid, Laurie Quinn, Minsun Park, Ali Cinar
    Journal of Diabetes Science and Technology.2023; 17(6): 1456.     CrossRef
  • Advanced Technology (Continuous Glucose Monitoring and Advanced Hybrid Closed-Loop Systems) in Diabetes from the Perspective of Gender Differences
    Maria Grazia Nuzzo, Marciano Schettino
    Diabetology.2023; 4(4): 519.     CrossRef
  • Artificial Pancreas under a Zone Model Predictive Control based on Gaussian Process models: toward the personalization of the closed loop
    Marco Polver, Beatrice Sonzogni, Mirko Mazzoleni, Fabio Previdi, Antonio Ferramosca
    IFAC-PapersOnLine.2023; 56(2): 9642.     CrossRef
  • Personalized Constrained MPC for glucose regulation
    Chiara Toffanin, Lalo Magni
    IFAC-PapersOnLine.2023; 56(2): 9648.     CrossRef
  • Automated Insulin Delivery Systems in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-analysis of Outpatient Randomized Controlled Trials
    Baoqi Zeng, Le Gao, Qingqing Yang, Hao Jia, Feng Sun
    Diabetes Care.2023; 46(12): 2300.     CrossRef
  • Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study
    Eun Yeong Ha, Seung Min Chung, Il Rae Park, Yin Young Lee, Eun Young Choi, Jun Sung Moon
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: A meta‐analysis
    Baoqi Zeng, Hao Jia, Le Gao, Qingqing Yang, Kai Yu, Feng Sun
    Diabetes, Obesity and Metabolism.2022; 24(10): 1967.     CrossRef
  • Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Systematic Review
    Alezandra Torres-Castaño, Amado Rivero-Santana, Lilisbeth Perestelo-Pérez, Andrea Duarte-Díaz, Analia Abt-Sacks, Vanesa Ramos-García, Yolanda Álvarez-Pérez, Ana M. Wäagner, Mercedes Rigla, Pedro Serrano-Aguilar
    Applied Sciences.2022; 12(20): 10262.     CrossRef
  • History of insulin treatment of pediatric patients with diabetes in Korea
    Jae Hyun Kim, Choong Ho Shin, Sei Won Yang
    Annals of Pediatric Endocrinology & Metabolism.2021; 26(4): 237.     CrossRef
Response
Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2021;45:379-89)
Inha Jung, Eun-Jung Rhee, Won-Young Lee
Diabetes Metab J. 2021;45(5):793-794.   Published online September 30, 2021
DOI: https://doi.org/10.4093/dmj.2021.0222
  • 7,556 View
  • 78 Download
  • 3 Crossref
PDFPubReader   ePub   

Citations

Citations to this article as recorded by  
  • Predicting depression severity using machine learning models: Insights from mitochondrial peptides and clinical factors
    Toheeb Salahudeen, Maher Maalouf, Ibrahim (Abe) M. Elfadel, Herbert F. Jelinek, Ian James Martins
    PLOS One.2025; 20(5): e0320955.     CrossRef
  • Impact of type 2 diabetes on the risk of cardiovascular disease and cardiovascular mortality in patients with non-alcoholic fatty liver disease: a nationwide population-based study
    Eun Roh, Han Na Jung, Ji Hye Heo, Kyungdo Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
    BMJ Public Health.2025; 3(1): e002020.     CrossRef
  • Recurrent depression relates to worse outcomes than single episode depression among Hispanic adolescents with diabetes
    Keiliany Rivera-Santiago, Eduardo Cumba-Aviles, Demivette Gómez-Rivera
    Health Psychology Report.2023;[Epub]     CrossRef
Original Article
Cardiovascular risk/Epidemiology
Article image
Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study
Inha Jung, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Yang-Hyun Kim, Eun-Jung Rhee, Won-Young Lee
Diabetes Metab J. 2021;45(3):379-389.   Published online December 11, 2020
DOI: https://doi.org/10.4093/dmj.2020.0008
  • 15,583 View
  • 296 Download
  • 46 Web of Science
  • 45 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Previous studies have suggested that depression in patients with diabetes is associated with worse health outcomes. The aim of this study was to evaluate the risk of cardiovascular disease (CVD) and mortality in patients with diabetes with comorbid depression.
Methods
We examined the general health check-up data and claim database of the Korean National Health Insurance Service (NHIS) of 2,668,615 participants with type 2 diabetes mellitus who had examinations between 2009 and 2012. As NHIS database has been established since 2002, those who had been diagnosed with depression or CVD since 2002 were excluded. The 2,228,443 participants were classified into three groups according to the claim history of depression; normal group (n=2,166,979), transient depression group (one episode of depression, n=42,124) and persistent depression group (at least two episodes of depression, n=19,340). The development of CVD and mortality were analyzed from 2009 to 2017.
Results
Those with depression showed a significantly increased risk for stroke (transient depression group: hazard ratio [HR], 1.20; 95% confidence interval [CI], 1.15 to 1.26) (persistent depression group: HR, 1.54; 95% CI, 1.46 to 1.63). Those with depression had an increased risk for myocardial infarction (transient depression group: HR, 1.25; 95% CI, 1.18 to 1.31) (persistent depression group: HR, 1.38; 95% CI, 1.29 to 1.49). The persistent depression group had an increased risk for all-cause mortality (HR, 1.66; 95% CI, 1.60 to 1.72).
Conclusion
Coexisting depression in patients with diabetes has a deleterious effect on the development of CVD and mortality. We suggest that more attention should be given to patients with diabetes who present with depressive symptoms.

Citations

Citations to this article as recorded by  
  • Mental Disorders as a Risk Factor of Acute Coronary Syndrome
    Arnav Gupta, Tushar Tejpal, Chanhee Seo, Nicholas Fabiano, Selina Zhao, Stanley Wong, Yuan Qiu, Jenna MacNeil, Dain R. Kim, Natasha Aleksova, Sara Siddiqi, Marco Solmi, Jess G. Fiedorowicz
    JAMA Psychiatry.2026; 83(3): 259.     CrossRef
  • Depression in Type 2 Diabetes: Association with Higher Insulin Resistance and Increased Low Grade Inflammation
    Jelena Stanarcic Gajovic, Dusica Lecic Tosevski, Katarina Lalic, Tanja Milicic, Ljiljana Lukic, Marija Macesic, Milica Stoiljkovic, Mina Bozic, Djurdja Rafailovic, Nikola Jovanovic, Olivera Vukovic, Sanja Stankovic, Ognjen Milicevic, Stefan Maric, Nina Kr
    Diabetology.2026; 7(3): 51.     CrossRef
  • Depression severity and cardiovascular risk in patients with type 2 diabetes mellitus: insights from the framingham risk score
    Soghra Aliasgharzadeh, Neda Lotfi Yagin, Nazli Namazi, Sajjad Haji, Naimeh Mesri Alamdari, Samira Pourmoradian, Ziba Ghorbanverdi, Majid Mobasseri
    Scientific Reports.2026;[Epub]     CrossRef
  • Antidepressants and Risk of Mortality in People with Depressive Disorder and Co-Occurring Type 2 Diabetes Mellitus: A 20-Year Population-Based Cohort Study
    Matthew Tsz Ho Ho, Joe Kwun Nam Chan, Heidi Ka Ying Lo, Catherine Zhiqian Fang, Corine Sau Man Wong, Krystal Chi Kei Lee, Francisco Tsz Tsun Lai, Amy Pui Pui Ng, William Chi Wai Wong, Wing Chung Chang
    Psychotherapy and Psychosomatics.2026; : 1.     CrossRef
  • ЦУКРОВИЙ ДІАБЕТ 2 ТИПУ, НЕЙРОКОГНІТИВНІ РОЗЛАДИ І ОМЕГА-3 ПОЛІНЕНАСИЧЕНІ ЖИРНІ КИСЛОТИ (огляд лiтератури)
    Олександр Сергієнко, Вероніка Сегін, Віталій Сулима, Вікторія Сергієнко
    Problems of Endocrine Pathology.2026; 83(1): 52.     CrossRef
  • Association between myocardial infarction and depression: bidirectional links and shared risk pathways—a systematic review and meta-analysis
    Konstantina-Maria Panoutsopoulou, Nikolaos-Stefanos Bastas, Dimitrios Tsartsalis, Aikaterini Grammeniati, Maria Efstathiou, Mary Gouva, Katerina K Naka, Elena Dragioti
    European Journal of Preventive Cardiology.2026;[Epub]     CrossRef
  • The Impact of Mental Health Disorders on Mortality Rates in Patients with Type 2 Diabetes Mellitus (Systematic Literature Review)
    Nadia Putri, Rohman Dakab, Sely Anggraini, Iis Puspitasari, Aprilia Rambe, Reztika Cahyani, Lisa Desi Arimbi, Andang Evrilianto, M. Abdul Hamid Zubair, Sonia Annisa Br Ketaren, Jennifer Irene A. Hadiono, Yuni Kartika, Tuti Alawiyah, Firdaus Firdaus, Noval
    F1000Research.2026; 15: 753.     CrossRef
  • Antidiabetes agents and risk of incident depression in 686,522 people with type 2 diabetes mellitus: A 20-year population-based cohort study
    Matthew Tsz Ho Ho, Joe Kwun Nam Chan, Heidi Ka Ying Lo, Catherine Zhiqian Fang, Corine Sau Man Wong, Krystal Chi Kei Lee, Francisco Tsz Tsun Lai, Amy Pui Pui Ng, William Chi Wai Wong, Wing Chung Chang
    Psychological Medicine.2026;[Epub]     CrossRef
  • Pathomorphological Features of Diabetic Myopathy in Comorbid Conditions
    Oksana Zhurakivska, Aleksandra Natalia Gabren-Syller, Oleh Koshkin, Viktor Mazurenko, Ivan Paliichuk, Nataliia Pyliachyk
    Journal of Molecular Pathology.2026; 7(2): 23.     CrossRef
  • Age-dependent association of uric acid levels with depressive symptoms in adults: NHANES 2007–2018
    Cong Yao, Guoshuai Luo, Meng Zhang, Yunsheng Fu, Xin Liu, Zonglin Li, Zipeng Chen, Jie Li
    Journal of Neural Transmission.2026;[Epub]     CrossRef
  • Co-occurring diabetes and depression and their impact on CVD, CAD, and stroke risk over a 10-year follow-up: A cohort study
    Hossein Ghazaee, Vahid Mahdavizadeh, Ali Rezaee, Susan Darroudi, Mohsen Rezaee, Habibollah Esmaily, Mohsen Mehrabzadeh, Hediye Erfaniyan Shahabi, Hoda Sabbagh Sajadiyeh, Reihaneh Alizadeh, Majid Ghayour-Mobarhan, Zahra Mazloum Khorasani
    Journal of Diabetes & Metabolic Disorders.2026;[Epub]     CrossRef
  • Risk of mortality and complications in people with depressive disorder and co-occurring diabetes mellitus: a systematic review and meta-analysis
    Matthew Tsz Ho Ho, Kwun Nam Chan, Will Chi Yuen Chiu, Lucy Lo Wah Tsang, Heidi Ka Ying Lo, Steven Yiu Long Wong, Kenneth Shut Wah Chan, Mimi Mei Cheung Wong, Ho Hon Wong, Wai Chung Lam, Pui Fai Pang, Wing Chung Chang
    Epidemiology and Psychiatric Sciences.2026;[Epub]     CrossRef
  • Risk of mortality and complications in people with depressive disorder and diabetes mellitus: A 20-year population-based propensity score-matched cohort study
    Matthew Tsz Ho Ho, Joe Kwun Nam Chan, Heidi Ka Ying Lo, Catherine Zhiqian Fang, Corine Sau Man Wong, Krystal Chi Kei Lee, Francisco Tsz Tsun Lai, Amy Pui Pui Ng, Ken Qingqi Chen, William Chi Wai Wong, Wing Chung Chang
    European Neuropsychopharmacology.2025; 92: 10.     CrossRef
  • Epidemiological insights into chronic urticaria, vitiligo, alopecia areata, and herpes zoster following COVID‐19 infection: A nationwide population‐based study
    Min Hee Kim
    The Journal of Dermatology.2025; 52(3): 499.     CrossRef
  • The association between C-reactive protein-albumin-lymphocyte index and depression in adults with type 2 diabetes mellitus: A cross-sectional study from NHANES
    Wei Hu, Qian Yuan, Jie Hu, Mingzi Li, Yue Xi, Ling Luo
    Psychoneuroendocrinology.2025; 176: 107442.     CrossRef
  • Type 2 diabetes mellitus, cerebral small vessel disease and depressive disorders
    V.A. Serhiyenkо, O.M. Chemerys, V.I. Pankiv, A.A. Serhiyenko
    INTERNATIONAL NEUROLOGICAL JOURNAL.2025; 21(3): 226.     CrossRef
  • The neutrophil percentage-to-albumin ratio mediates the association between depression and all-cause mortality in U.S. adults: Evidence from NHANES 2009–2018
    Kunxiu Wang, Gaofeng Liu, Yuchen Pan, Siyu Li, Xiaoling Zhu, Hui Qu, Xuesong Liang, Song Chen, Wenbin Fu
    Journal of Affective Disorders.2025; 389: 119736.     CrossRef
  • Healthcare resource utilization of people with depressive disorder and co-occurring incident diabetes mellitus: A 20-year population-based propensity score-matched cohort study
    Matthew Tsz Ho Ho, Joe Kwun Nam Chan, Heidi Ka Ying Lo, Catherine Zhiqian Fang, Corine Sau Man Wong, Krystal Chi Kei Lee, Wing Chung Chang
    General Hospital Psychiatry.2025; 96: 244.     CrossRef
  • Prevalence and risk factors of depression in middle-aged and elderly women with diabetes: a protocol of systematic review and meta-analysis
    Yiting Pan, Longhan Zhang, An Luo, Yaqing Liu, Hao Bai, Lingqiao Song, Zeyuan Long, Li Liao
    BMJ Open.2025; 15(10): e104902.     CrossRef
  • The Bidirectional Relationship Between Myocardial Infarction and Depression: Risk Factors, Mechanisms, and Interventions
    Zhuorui Cui, Qiaoning Yang, Furong Yang, Yankai Yang, Xuexin Yang, Yanqiao Yu, Yajie Cai, Xiaodi Fan, Ruina Bai
    Biomedicines.2025; 13(11): 2838.     CrossRef
  • Psychological resilience mediates the relationship between diabetes distress and depression among persons with diabetes in a multi-group analysis
    Ajele Kenni Wojujutari, Erhabor Sunday Idemudia, Lawrence Ejike Ugwu
    Scientific Reports.2024;[Epub]     CrossRef
  • CVD incidence and mortality among people with diabetes and/or hypertension: Results from the English longitudinal study of ageing
    Paola Zaninotto, Andrew Steptoe, Eun-Jung Shim, Attila Csaba Nagy
    PLOS ONE.2024; 19(5): e0303306.     CrossRef
  • Impact of mental disorders on the all-cause mortality and cardiovascular disease outcomes in adults with new-onset type 1 diabetes: A nationwide cohort study
    Seohyun Kim, Gyuri Kim, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
    Psychiatry Research.2024; 342: 116228.     CrossRef
  • Individual and joint effects of diabetes and depression on incident cardiovascular diseases and all-cause mortality: Results from a population-based cohort study
    Qiang Tu, Karice Hyun, Shuanglan Lin, Nashid Hafiz, Deborah Manandi, Qian Zhang, Xinzheng Wang, Na Zhang, Haisheng Wu, Julie Redfern
    Journal of Diabetes and its Complications.2024; 38(11): 108878.     CrossRef
  • A Nationwide Population-Based Study for Audio-Vestibular Disorders following COVID-19 Infection
    Hye Yeon Ko, Min Hee Kim
    Audiology and Neurotology.2024; 30(3): 245.     CrossRef
  • The mediating effect of depression on new-onset stroke in diabetic population: Evidence from the China health and retirement longitudinal study
    Gege Jiang, Yaoling Wang, Liping Wang, Minfang Chen, Wei Li
    Journal of Affective Disorders.2023; 321: 208.     CrossRef
  • Frailty and outcomes in lacunar stroke
    Sima Vazquez, Zehavya Stadlan, Justin M Lapow, Eric Feldstein, Smit Shah, Ankita Das, Alexandria F Naftchi, Eris Spirollari, Akash Thaker, Syed Faraz Kazim, Jose F Dominguez, Neisha Patel, Christeena Kurian, Ji Chong, Stephan A Mayer, Gurmeen Kaur, Chirag
    Journal of Stroke and Cerebrovascular Diseases.2023; 32(2): 106942.     CrossRef
  • Comparison of Operational Definition of Type 2 Diabetes Mellitus Based on Data from Korean National Health Insurance Service and Korea National Health and Nutrition Examination Survey
    Jong Ha Baek, Yong-Moon Park, Kyung Do Han, Min Kyong Moon, Jong Han Choi, Seung-Hyun Ko
    Diabetes & Metabolism Journal.2023; 47(2): 201.     CrossRef
  • The Association between Dietary Carotenoid Intake and Risk of Depression among Patients with Cardiometabolic Disease
    Jie Liang, Yuhao Wang, Min Chen
    International Heart Journal.2023; 64(2): 223.     CrossRef
  • Associations of concomitant retinopathy and depression with mortality in a nationally representative population
    Zheng Lyu, Yilin Chen, Zhuoting Zhu, Xiaoyang Luo, Ying Cui, Jie Xie, Zhifan Chen, Junbin Liu, Xiyu Wu, Gabrella Bulloch, Qianli Meng
    Journal of Affective Disorders.2023; 336: 15.     CrossRef
  • Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses
    Chiara Possidente, Giuseppe Fanelli, Alessandro Serretti, Chiara Fabbri
    Neuroscience & Biobehavioral Reviews.2023; 152: 105298.     CrossRef
  • Prevalence of depression and association with all-cause and cardiovascular mortality among individuals with type 2 diabetes: a cohort study based on NHANES 2005–2018 data
    Zhen Feng, Wai Kei Tong, Xinyue Zhang, Zhijia Tang
    BMC Psychiatry.2023;[Epub]     CrossRef
  • Cholecystectomy Increases the Risk of Type 2 Diabetes in the Korean Population
    Ji Hye Huh, Kyong Joo Lee, Yun Kyung Cho, Shinje Moon, Yoon Jung Kim, Eun Roh, Kyung-do Han, Dong Hee Koh, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
    Annals of Surgery.2023; 278(2): e264.     CrossRef
  • Risk of depression in patients with acromegaly in Korea (2006-2016): a nationwide population-based study
    Shinje Moon, Sangmo Hong, Kyungdo Han, Cheol-Young Park
    European Journal of Endocrinology.2023; 189(3): 363.     CrossRef
  • The association between cardiovascular drugs and depression/anxiety in patients with cardiovascular disease: A meta-analysis
    Lijun Zhang, Yanping Bao, Shuhui Tao, Yimiao Zhao, Meiyan Liu
    Pharmacological Research.2022; 175: 106024.     CrossRef
  • Association of mental health with the risk of coronary artery disease in patients with diabetes: A mendelian randomization study
    Teng Hu, Fangkun Yang, Kewan He, Jiajun Ying, Hanbin Cui
    Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(3): 703.     CrossRef
  • Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease
    Mengmeng Zhu, Yiwen Li, Binyu Luo, Jing Cui, Yanfei Liu, Yue Liu
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research
    Dae-Sung Kyoung, Hun-Sung Kim
    Journal of Lipid and Atherosclerosis.2022; 11(2): 103.     CrossRef
  • Evaluating Triglyceride and Glucose Index as a Simple and Easy-to-Calculate Marker for All-Cause and Cardiovascular Mortality
    Kyung-Soo Kim, Sangmo Hong, You-Cheol Hwang, Hong-Yup Ahn, Cheol-Young Park
    Journal of General Internal Medicine.2022; 37(16): 4153.     CrossRef
  • Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats
    Himanshu Verma, Anindita Bhattacharjee, Naveen Shivavedi, Prasanta Kumar Nayak
    Naunyn-Schmiedeberg's Archives of Pharmacology.2022; 395(10): 1189.     CrossRef
  • Lipid cutoffs for increased cardiovascular disease risk in non-diabetic young people
    Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Kun-Ho Yoon, Seung-Hwan Lee
    European Journal of Preventive Cardiology.2022; 29(14): 1866.     CrossRef
  • Risk factors associated with mortality among individuals with type 2 diabetes and depression across two cohorts
    Christopher Rohde, Jens Steen Nielsen, Jakob Schöllhammer Knudsen, Reimar Wernich Thomsen, Søren Dinesen Østergaard
    European Journal of Endocrinology.2022; 187(4): 567.     CrossRef
  • Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2021;45:379-89)
    Jin Hwa Kim
    Diabetes & Metabolism Journal.2021; 45(5): 789.     CrossRef
  • Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2021;45:379-89)
    Inha Jung, Eun-Jung Rhee, Won-Young Lee
    Diabetes & Metabolism Journal.2021; 45(5): 793.     CrossRef
  • Affective Temperament and Glycemic Control – The Psychological Aspect of Obesity and Diabetes Mellitus
    Natalia Lesiewska, Anna Kamińska, Roman Junik, Magdalena Michalewicz, Bartłomiej Myszkowski, Alina Borkowska, Maciej Bieliński
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 4981.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP